Physician profile
Grace E Varilone
NPI 1841540606
$3,044.38
in general payments reported to CMS, 2019-2025
12 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $469 · 2023: $1,436 · 2024: $402 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Travel and Lodging: $783 · Education: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.90 |
| Travel and Lodging | $783.12 |
| Education | $421.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,737.85 | 2021-2024 | Senza |
| Averitas Pharma INC. | $198.57 | 2024-2025 | Qutenza |
| Abbvie INC. | $174.11 | 2022-2025 | |
| Allergan, INC. | $169.31 | 2021 | |
| Stryker Corporation | $162.34 | 2025 | Mild Device Kit |
| Abbott Laboratories | $145.70 | 2024 | Proclaim |
| Teva Pharmaceuticals USA, INC. | $121.63 | 2022 | |
| Grt US Holding, INC. | $116.67 | 2022 | |
| Medtronic, INC. | $93.76 | 2022 | |
| Spr Therapeutics, INC | $64.00 | 2023 | Sprint Pns System |
| Curonix LLC | $43.78 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $16.66 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Varilone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.